Eculizumab
monoclonal antibody · rare diseases
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
In pharmacological terms, Eculizumab belongs to the “monoclonal antibody (rare diseases)” category. This medicine belongs to the “Other areas” field. Its indication is specific and set by the prescription.
For Eculizumab, in practice: Treats certain rare diseases of the blood and kidney. How it is used depends on the situation, within the framework set by the doctor.
Under which brands it is found
Eculizumab is found in around 3 presentations listed in France. It is available under various brand names and as generics.
- Bekemv
- Epysqli
- Soliris
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
For Eculizumab, we offer no supplement. No nutritional supplementation is seriously justified as an addition to this treatment, and we would rather write that than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; outside of those, we do not sell for the sake of selling, and that is what gives weight to our five products.
Related molecules
To explore in the « Other areas » family and its neighbours.